To hear about similar clinical trials, please enter your email below
Trial Title:
Radiomics in Pancreatic Cancer
NCT ID:
NCT05658679
Condition:
Pancreatic Cancer
Conditions: Official terms:
Pancreatic Neoplasms
Study type:
Observational
Overall status:
Active, not recruiting
Study design:
Time perspective:
Retrospective
Summary:
The images of patients with pancreatic cancer were collected and analyzed based on the
methodes of radiomics
Criteria for eligibility:
Study pop:
All participants willing to receive abdominal imaging could be included in this study
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Gender unlimited, 18-80 years old;
- Received abdominal imaging;
- informed consent signed.
Exclusion Criteria:
- Pregnant / lactating womenï¼›
- Contraindications of imaging examination。
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
Accepts Healthy Volunteers
Start date:
January 2016
Completion date:
December 2024
Lead sponsor:
Agency:
Ruijin Hospital
Agency class:
Other
Source:
Ruijin Hospital
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05658679
